As most Gulf markets ease due to falling oil prices and investor caution, the Middle Eastern financial landscape presents a mixed picture of opportunities and challenges. In such conditions, penny stocks—often representing smaller or newer companies—can offer unique investment potential when they exhibit strong financials. Despite their outdated name, these stocks remain relevant for investors seeking affordable options with growth potential.
Top 10 Penny Stocks In The Middle East
| Name | Share Price | Market Cap | Rewards & Risks |
| Thob Al Aseel (SASE:4012) | SAR4.00 | SAR1.6B | ✅ 2 ⚠️ 1 View Analysis > |
| Dna Group (T.R.) (TASE:DNA) | ₪1.001 | ₪123.29M | ✅ 2 ⚠️ 4 View Analysis > |
| Alarum Technologies (TASE:ALAR) | ₪2.479 | ₪173.61M | ✅ 4 ⚠️ 2 View Analysis > |
| Oil Refineries (TASE:ORL) | ₪0.918 | ₪2.85B | ✅ 1 ⚠️ 2 View Analysis > |
| Tgi Infrastructures (TASE:TGI) | ₪2.111 | ₪156.94M | ✅ 2 ⚠️ 2 View Analysis > |
| Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) | AED0.69 | AED419.7M | ✅ 2 ⚠️ 2 View Analysis > |
| Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) | AED3.67 | AED423.88M | ✅ 2 ⚠️ 4 View Analysis > |
| Union Insurance Company P.J.S.C (ADX:UNION) | AED0.601 | AED198.89M | ✅ 2 ⚠️ 4 View Analysis > |
| E7 Group PJSC (ADX:E7) | AED1.05 | AED2.12B | ✅ 3 ⚠️ 2 View Analysis > |
| Dubai Investments PJSC (DFM:DIC) | AED2.32 | AED9.91B | ✅ 3 ⚠️ 3 View Analysis > |
Click here to see the full list of 94 stocks from our Middle Eastern Penny Stocks screener.
Let's uncover some gems from our specialized screener.
Ege Seramik Sanayi ve Ticaret (IBSE:EGSER)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Ege Seramik Sanayi ve Ticaret A.S. is a company that produces and sells ceramic floor and wall tiles globally, with a market capitalization of TRY2.27 billion.
Operations: The company generates revenue of TRY2.69 billion from its Building Products segment, which includes ceramic floor and wall tiles.
Market Cap: TRY2.27B
Ege Seramik Sanayi ve Ticaret faces challenges as a penny stock, with declining revenues of TRY2.69 billion and a significant net loss of TRY890 million for 2024. Despite its unprofitability, the company's short-term assets exceed both its short and long-term liabilities, indicating some financial stability. The management team is experienced with an average tenure of 15.3 years, which could provide strategic guidance during turbulent times. However, the rising debt-to-equity ratio from 4.9% to 24.9% over five years signals increasing leverage risks that investors should monitor closely in this volatile segment.
- Unlock comprehensive insights into our analysis of Ege Seramik Sanayi ve Ticaret stock in this financial health report.
- Review our historical performance report to gain insights into Ege Seramik Sanayi ve Ticaret's track record.
Elbit Medical Technologies (TASE:EMTC-M)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Elbit Medical Technologies Ltd is an investment holding company involved in the research, development, production, and marketing of therapeutic medical systems across the United States, Europe, and internationally, with a market cap of ₪19.05 million.
Operations: Elbit Medical Technologies Ltd has not reported any specific revenue segments.
Market Cap: ₪19.05M
Elbit Medical Technologies Ltd, with a market cap of ₪19.05 million, has transitioned to profitability recently, reporting a net income of US$0.827 million for 2024 compared to a significant loss the previous year. Despite its high share price volatility and low Return on Equity at 10.3%, the company benefits from having no debt and strong short-term liquidity as its assets exceed liabilities significantly. Its Price-To-Earnings ratio of 6.4x suggests it may be undervalued relative to the local market average, though investors should note its reliance on non-cash earnings and limited revenue generation historically under US$1 million annually.
- Click here to discover the nuances of Elbit Medical Technologies with our detailed analytical financial health report.
- Evaluate Elbit Medical Technologies' historical performance by accessing our past performance report.
Massivit 3D Printing Technologies (TASE:MSVT)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Massivit 3D Printing Technologies Ltd is a company that provides industrial 3D printing systems in Italy and internationally, with a market cap of ₪24.23 million.
Operations: The company's revenue is derived from selling printers and related consumables, totaling $4.89 million.
Market Cap: ₪24.23M
Massivit 3D Printing Technologies Ltd, with a market cap of ₪24.23 million, reported a significant decline in sales to US$4.89 million for 2024 from US$12.62 million the previous year, alongside an increased net loss of US$16.16 million. Despite its unprofitability and high share price volatility, the company maintains strong liquidity with short-term assets of $17.7M exceeding both short-term and long-term liabilities significantly. The debt-to-equity ratio has dramatically improved over five years to 0.03%, yet cash runway concerns persist as it holds less than a year's worth based on current free cash flow trends.
- Click to explore a detailed breakdown of our findings in Massivit 3D Printing Technologies' financial health report.
- Gain insights into Massivit 3D Printing Technologies' historical outcomes by reviewing our past performance report.
Turning Ideas Into Actions
- Click through to start exploring the rest of the 91 Middle Eastern Penny Stocks now.
- Ready To Venture Into Other Investment Styles? We've found 19 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Massivit 3D Printing Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com